AbbVie Inc (ABBV)

108.40
-1.09(-1.00%)
After Hours
108.66
+0.26(+0.24%)
- Real-time Data
  • Volume:
    4,628,442
  • Bid/Ask:
    108.41/108.66
  • Day's Range:
    108.17 - 109.72

ABBV Overview

Prev. Close
109.49
Day's Range
108.17-109.72
Revenue
53.73B
Open
109.58
52 wk Range
79.11-121.53
EPS
3.72
Volume
4,628,442
Market Cap
191.56B
Dividend (Yield)
5.20
(4.75%)
Average Volume (3m)
7,040,375
P/E Ratio
29.47
Beta
0.78
1-Year Change
31.06%
Shares Outstanding
1,767,175,532
Next Earnings Date
28 Oct 2021
What is your sentiment on AbbVie Inc?
or
Market is currently closed. Voting is open during market hours.

AbbVie Inc News

AbbVie Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellSellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

AbbVie Inc Company Profile

AbbVie Inc Company Profile

Employees
48000

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Read More
  • Abbv going up again.
    0
    • What is happening to abbvie?
      0
      • ABBV : FDA requires updated warnings on JAK inhibitors citing increased risks of heart events10:56 am, Wed, Sep. 1, 2021
        0
    • Bullish guys
      0
      • Hi how will be EUR/USD next week
        8
        • Cloudy with a chance of rain
          0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.